Bone News and Research

RSS

Higher calcium intake appears to mitigate impact of some of the risk genes for type 2 diabetes

Study shows calcium intake mitigates genetic risk for increased body fat in African-American children, a population with historically low calcium intake and high risk for diabetes.

29 Apr 2014

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC, for the first quarter ended March 29, 2014.

29 Apr 2014

Tips to improve bone health

As many as 52 million Americans have osteoporosis and low bone mass, and studies suggest that one in two women and up to one in four men ages 50 and older will break a bone due to osteoporosis. Osteoporosis is concerning because you can't feel your bones getting weaker, which is why it's often referred to as the "silent disease." May is National Osteoporosis Month and, since prunes have been linked to bone health, Sunsweet is urging Americans to listen to their bones this month and start taking action to keep bones strong and healthy.

29 Apr 2014

Professor offers water-safety tips to prevent young children from getting sick

There is nothing better on a hot, summer day than a refreshing dip in a community pool, water park, lake or ocean. However, bacteria and parasites can lurk in all kinds of water and put a real damper on summertime fun unless people practice a few, simple safety tips.

29 Apr 2014

Study: Mutations could have major impact on treatment of human blood diseases

A study published today in Nature Genetics has revealed mutations that could have a major impact on the future diagnosis and treatment of many human diseases.

29 Apr 2014

Doctors, dentists adjusting to ups and downs of changing U.S. health care system

The recent economic downturn and the increasing use of high-deductible insurance plans "has driven patients to want to put off paying their bills," Michael explains. Whether it's for a hip replacement or a broken bone, he frequently sees patients on the hook for a $3,000 to $5,000 deductible (Gold, 4/25).

26 Apr 2014

Engineering breakthrough allows cancer researchers to create living tumors

Drexel's Wei Sun, PhD, Albert Soffa chair professor in the College of Engineering, has devised a method for 3D printing tumors that could soon be taking cancer research out of the petri dish.

26 Apr 2014

First Edition: April 25, 2014

Today's headlines include reports about a recommendation that Oregon switch its troubled health exchange from a state-run marketplace to healthcare.gov.

25 Apr 2014

Tolero Pharmaceuticals' Alvocidib gets Orphan Drug Designation for acute myeloid leukemia treatment

Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).

23 Apr 2014

Research grants could improve patients' recovery from athletic and nonathletic injuries

Two orthopedic organizations have presented Beaumont Health System with prestigious, competitive research grants that could improve patients' recovery from both athletic and nonathletic injuries.

23 Apr 2014

Biting into whole foods can make children rowdy

There's a new secret to get your child to behave at the dinner table-cut up their food and they'll relax. A new Cornell study published in Eating Behaviors, found that when 6-10 year old children ate foods they had to bite with their front teeth- such as drumsticks, whole apples, or corn on the cob- they were rowdier than when these foods had been cut.

23 Apr 2014

Interleukin receives conditional approval to offer results of PerioPredict genetic risk test

Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test for periodontal disease.

22 Apr 2014

DePuy Synthes CMF announces launch of Patient Specific Plates for Mandible

DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction and part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of Patient Specific Plates for Mandible (PSPM), new plates that are customized based on surgeon specifications and individual patient anatomy.

21 Apr 2014

FDA and EC grant Orphan Drug Designation to Boehringer’s volasertib for acute myeloid leukemia

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).

21 Apr 2014

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

Kessler Foundation has been named awardee of a three-year grant for $1.8 million from the Department of Defense Spinal Cord Injury Research Program. Gail Forrest, PT, PhD, is principal investigator for the randomized, double-blinded, controlled, multi-site clinical trial, which will test strategies to improve bone and muscle strength after spinal cord injury. Dr. Forrest is assistant director of Human Performance & Engineering Research at Kessler Foundation.

18 Apr 2014

Hydrogen sulfide regulates bone marrow mesenchymal stem cells, shows study

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry of USC.

18 Apr 2014

Boehringer grants volasertib 'orphan drug designation' for treatment of patients with AML

Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) and the European Commission have granted volasertib* 'orphan drug designation' for the treatment of patients with acute myeloid leukaemia (AML).

17 Apr 2014

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.

17 Apr 2014

New syndrome osteosarcopenic obesity links deterioration of bone density and muscle mass with obesity

Florida State University researchers have identified a new syndrome called "osteosarcopenic obesity" that links the deterioration of bone density and muscle mass with obesity.

17 Apr 2014

Researchers coax human embryonic stem cells to turn into working spinal cord cells

The sponginess of the environment where human embryonic stem cells are growing affects the type of specialized cells they eventually become, a University of Michigan study shows.

16 Apr 2014

Bone News and Research

Higher calcium intake appears to mitigate impact of some of the risk genes for type 2 diabetes

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

Tips to improve bone health

Professor offers water-safety tips to prevent young children from getting sick

Study: Mutations could have major impact on treatment of human blood diseases

Doctors, dentists adjusting to ups and downs of changing U.S. health care system

Engineering breakthrough allows cancer researchers to create living tumors

First Edition: April 25, 2014

Tolero Pharmaceuticals' Alvocidib gets Orphan Drug Designation for acute myeloid leukemia treatment

Research grants could improve patients' recovery from athletic and nonathletic injuries

Biting into whole foods can make children rowdy

Interleukin receives conditional approval to offer results of PerioPredict genetic risk test

DePuy Synthes CMF announces launch of Patient Specific Plates for Mandible

FDA and EC grant Orphan Drug Designation to Boehringer’s volasertib for acute myeloid leukemia

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

Hydrogen sulfide regulates bone marrow mesenchymal stem cells, shows study

Boehringer grants volasertib 'orphan drug designation' for treatment of patients with AML

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

New syndrome osteosarcopenic obesity links deterioration of bone density and muscle mass with obesity

Researchers coax human embryonic stem cells to turn into working spinal cord cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News